Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Monday, July 07, 2014 11:56:08 AM
bullish weekly trade 6% (=26% a month)
these kind of trades are best with a few grand in each, since the percent return is low to make the profit worthwhile considering the trade commission, but it is an often overlooked profit opportunity that is constantly there
the less money you have to trade with, the more you have to buy and hold time-wise to make a good profit above commissions
$ONCY
DD Notes ~ http://www.ddnotesmaker.com/ONCY
##### recent news/filings ~ source: finance.yahoo.com
Thu, 26 Jun 2014 10:50:00 GMT ~ Prothena Corporation (PRTA) Falls: Stock Goes Down 5.3%
read full: http://finance.yahoo.com/news/prothena-corporation-prta-falls-stock-105000145.html
*********************************************************
Thu, 19 Jun 2014 10:30:00 GMT ~ Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders
[PR Newswire] - CALGARY, June 19, 2014 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that all nominees listed in the management information circular dated May 9, 2014 were elected as ...
read full: http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-director-103000735.html
*********************************************************
Thu, 19 Jun 2014 10:30:00 GMT ~ Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders
[CNW Group] - Oncolytics Biotech® Inc. Announces Director Election Results from its Annual Meeting of Shareholders
read full: http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-director-103000565.html
*********************************************************
Mon, 16 Jun 2014 10:30:00 GMT ~ Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders
[PR Newswire] - CALGARY, June 16, 2014 /PRNewswire/ - Oncolytics Biotech Inc. (TSX: ONC, NASDAQ: ONCY) announced today that its 2014 Annual Meeting of Shareholders will be held on Wednesday June 18th, 2014 at 4:30pm ET at the TMX Broadcast Centre, 130 King Street West, Toronto, ON Following the business portion of the meeting, Dr. Brad Thompson, President and CEO of Oncolytics, will discuss recent progress in the development of REOLYSIN® as a potential cancer therapeutic. Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN, its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.
read full: http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-details-103000679.html
*********************************************************
Mon, 16 Jun 2014 10:30:00 GMT ~ Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders
[CNW Group] - Oncolytics Biotech® Inc. Announces Details of 2014 Annual Meeting of Shareholders
read full: http://finance.yahoo.com/news/oncolytics-biotech-inc-announces-details-103000293.html
*********************************************************
##### chart ~ source: stockcharts.com
##### chart ~ source: eoddata.com
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ONCY/company-info
Ticker: $ONCY
OTC Market Place: Not Available
CIK code: 0001129928
Company name: Oncolytics Biotech Inc.
Incorporated In:
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001129928&owner=exclude&count=40
Latest filings: http://www.otcmarkets.com/stock/ONCY/filings
Latest financials: http://www.otcmarkets.com/stock/ONCY/financials
Latest news: http://www.otcmarkets.com/stock/ONCY/news - http://finance.yahoo.com/q/h?s=ONCY+Headlines
Major holdings: http://data.cnbc.com/quotes/ONCY/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=ONCY+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/ONCY.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=ONCY
RegSho: http://www.regsho.com/tools/symbol_stats.php?sym=ONCY&search=search
DTCC: http://search2.dtcc.com/?q=Oncolytics+Biotech+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Oncolytics+Biotech+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results?term=Oncolytics+Biotech+Inc.&x=0&y=0
Short Sales: http://www.otcmarkets.com/stock/ONCY/short-sales
Insider Disclosure: http://www.otcmarkets.com/stock/ONCY/insider-transactions
Research Reports: http://www.otcmarkets.com/stock/ONCY/research
Historical Prices: http://finance.yahoo.com/q/hp?s=ONCY+Historical+Prices
Basic Tech. Analysis: http://finance.yahoo.com/q/ta?s=ONCY+Basic+Tech.+Analysis
Company Profile: http://finance.yahoo.com/q/pr?s=ONCY+Profile
Key Statistics: http://finance.yahoo.com/q/ks?s=ONCY+Key+Statistics
Industry: http://finance.yahoo.com/q/in?s=ONCY+Industry
Insider Roster: http://finance.yahoo.com/q/ir?s=ONCY+Insider+Roster
Income Statement: http://finance.yahoo.com/q/is?s=ONCY
Balance Sheet: http://finance.yahoo.com/q/bs?s=ONCY
Cash Flow: http://finance.yahoo.com/q/cf?s=ONCY+Cash+Flow&annual
Market Watch: http://www.marketwatch.com/investing/stock/ONCY
Bloomberg: http://www.bloomberg.com/quote/ONCY:US
Morningstar: http://quotes.morningstar.com/stock/s?t=ONCY
Bussinessweek: http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ONCY
Barchart: http://www.barchart.com/quotes/stocks/ONCY
OTC Short Report: http://otcshortreport.com/index.php?index=ONCY
Investopedia: http://www.investopedia.com/markets/stocks/ONCY/?wa=0
http://www.pennystocktweets.com/stocks/profile/ONCY
##### last known share structure ~ source: otcmarkets.com
Market Value: $116,172,750 a/o Jul 03, 2014
Shares Outstanding: 84,803,818 a/o Dec 31, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
DD Notes ~ http://www.ddnotesmaker.com/ONCY
fi2wh
Recent ONCY News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/07/2024 09:06:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2024 06:08:24 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/04/2024 05:37:31 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/28/2024 06:09:09 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/14/2024 01:30:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/09/2024 01:44:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/04/2024 06:01:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/07/2023 03:37:42 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 06:21:43 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/09/2023 06:00:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 06:01:03 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 03:18:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/03/2023 03:17:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/23/2023 04:33:25 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/23/2023 04:26:14 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/20/2023 07:07:38 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2023 05:20:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/26/2023 04:32:20 PM
- THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS • PR Newswire (US) • 09/26/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/19/2023 09:28:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/06/2023 04:00:57 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2023 01:49:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/14/2023 12:41:18 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 07:14:10 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/04/2023 06:57:52 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM